Quantcast

Latest Macular degeneration Stories

2014-04-29 08:38:13

Transitions Optical to Supply Complimentary Eye Health Education Resources to NAHN Nurses Across the Country WASHINGTON, April 29, 2014 /PRNewswire/ -- Transitions Optical, Inc. and the National Association of Hispanic Nurses (NAHN) have announced a national partnership to reach Hispanic communities with eye health information. Transitions Optical has joined NAHN as a Corporate Member and will provide education to NAHN members on the higher risk for eye health issues among Hispanic...

2014-04-28 12:30:45

SEATTLE, April 28, 2014 /PRNewswire/ -- LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatment for ocular disorders and disease, today announced it is a recipient of a Washington State Life Sciences Discovery Award (LSDF) grant. LumiThera was 1 of 5 recipients of the LSDF grants each worth $250,000 to provide for proof of concept studies. As stated in the LSDF press release: "LSDF created the Proof of Concept granting...

2014-04-24 08:35:50

Renowned ophthalmic expert to provide critical guidance to MacuLogix HUMMELSTOWN, Pa., April 24, 2013 /PRNewswire/ -- MacuLogix, Inc., a pioneer in the early detection and tracking of age-related macular degeneration (AMD), today announced the appointment of Joan W. Miller, MD FARVO as a Clinical Advisor. Dr. Miller will provide MacuLogix with guidance on the development and commercialization of the Company's AdaptDx®, an advanced dark adaptometer used by eye care physicians to...

2014-04-22 23:11:07

Canadian artist, faced with losing his sight from macular degeneration, develops his own naturopathic protocol. After eleven weeks he has improved his sight from 20/400 blindness to 20/50 vision—and he's now planning to be back in his studio, hard at work on a new set of canvasses. Burnaby, BC, Canada (PRWEB) April 22, 2014 His opthamologist at the University of British Columbia says he's never seen anything like it. But Vancouver painter John Crittenden has beaten the odds...

2014-04-22 12:30:18

- Proceeds will Further Strengthen Avalanche's Proprietary BioFactoryTM Platform and Advance Clinical Program in Wet Age-Related Macular Degeneration - MENLO PARK, Calif., April 22, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc, a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the successful completion of a $55 million Series B financing. New investors were led by Venrock, and...

2014-04-22 08:28:14

Innovative, Tissue-Sparing, Cost-Effective Therapy MOUNTAIN VIEW, Calif., April 22, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that an educational story based on its innovative MicroPulse(TM) technology for the treatment of diabetic macular edema (DME) and age-related macular degeneration (AMD), was recently featured on the Washington, D.C. edition of "American Health Front," a health news program focused on advances in medical techniques and technologies....

2014-04-17 08:28:26

ST. LOUIS, April 17, 2014 /PRNewswire/ -- Did you know women are more likely to suffer from visual impairments like Age-related Macular Degeneration, Glaucoma, Diabetic Retinopathy, and Cataracts than men? According to the National Eye Institute (NEI), out of the 3.6 million Americans over 40 who suffer from optical damage or injury -- including blindness -- 2.3 million are women. That's why EyePromise is supporting Women's Eye Health and Safety Month throughout April. Logo -...

2014-04-15 16:28:05

SARATOGA, Calif., April 15, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two changes to its Board of Directors. Ophthalmic industry veteran, Mark Forchette has joined the board in a new seat; John Ryan is filling ONSET Ventures existing board seat. Mark Forchette brings thirty years of experience in ophthalmic sales, marketing and business unit...

2014-04-03 11:04:31

Scientists at Trinity College Dublin have made a major breakthrough with important implications for sufferers of the eye disease Age-Related Macular Degeneration (AMD), which can cause central blindness in sufferers. The scientists found that a component of the immune system, 'IL-18', acts as a guardian of eyesight by suppressing the production of damaging blood vessels behind the retina at the back of the eye. In addition, in pre-clinical models, it was shown that 'IL-18' can be...

2014-03-28 12:26:13

SARATOGA, Calif., March 28, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration, today announced two promotions within its management team. Chet Kumar has been appointed Vice President, Sales & Market Development; Mr. Kumar most recently was the Company's Vice President, Market & Business Development. Mr. Kumar has more than fifteen years of successful...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.